Correction

A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer

N Engl J Med 2006; 355:1746October 19, 2006

Article

A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer (Original Article, N Engl J Med 2004:350;1081 - 1092) . On page 1081, the list of authors should have included “Cornelius van de Velde, M.D., Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands.” On page 1083, the legend for Figure 1 should have read “The percentage of patients who continue to receive treatment represents the percentage who are not known to have discontinued their randomized treatment and who began initial tamoxifen therapy less than five years before March 31, 2004,” not “December 31, 2004,” as printed. On page 1089, in Figure 3, the upper limit of the 95 percent confidence interval for the previous-chemotherapy subgroup should have been 0.92 and should not have crossed 1.0, as printed. On page 1090, the P values listed in Table 4 were incorrect.

The table has been corrected on the Journal's Web site at www.nejm.org.